Physician profile
Christopher Charles Rhoades
NPI 1851310197
$664.77
in general payments reported to CMS, 2019-2025
12 companies · $75.72 in 2025
The $75.72 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2021: $16.61 · 2022: $50.76 · 2023: $107 · 2024: $150 · 2025: $75.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.53 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $150.00 | 2024 | |
| Centrix INC | $105.13 | 2019 | |
| Sonendo INC | $86.20 | 2023 | Gentlewave G4 Console |
| Premier Dental Products Company | $75.62 | 2019-2022 | |
| 3m Company | $49.28 | 2019-2021 | |
| Ultradent Products INC | $46.47 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $39.38 | 2023-2025 | Arestin |
| Align Technology, INC. | $32.22 | 2022-2025 | Invisalign |
| Henry Schein, INC. | $23.47 | 2022 | |
| Voco America INC. | $21.16 | 2025 | Voco Profluorid Varnish, Structur 2, Meron Plus Qm |
| Philips North America LLC | $18.64 | 2025 | Power Toothbrush Undivided |
| Kulzer, LLC | $17.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rhoades listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.